|
1
|
Feuer EJ, Wun LM, Boring CC, Flanders WD,
Timmel MJ and Tong T: The life time risk of developing breast
cancer. J Natl Cancer Inst. 85:892–897. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Condeelis J, Singer RH and Segall JE: The
great escape: When cancer cells hijack the genes for chemotaxis and
motility. Annu Rev Cell Dev Biol. 21:695–718. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feigin ME: Harnessing the genome for
characterization of G-protein coupled receptors in cancer
pathogenesis. FEBS J. 280:4729–4738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gilman AG: G proteins: Transducers of
receptor-generated signals. Annu Rev Biochem. 56:615–649. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross EM and Wilkie TM: GTPase-activating
proteins for heterotrimeric G proteins: Regulators of G protein
signaling (RGS) and RGS-like proteins. Annu Rev Biochem.
69:795–827. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao J, Michalek C, Zhang W, Zhu M, Xu X
and Mende U: Regulation of cardiomyocyte signaling by RGS proteins:
Differential selectivity towards G proteins and susceptibility to
regulation. J Mol Cell Cardiol. 41:51–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mittmann C, Chung CH, Höppner G, Michalek
C, Nose M, Schüler C, Schuh A, Eschenhagen T, Weil J, Pieske B, et
al: Expression of ten RGS proteins in human myocardium: Functional
characterization of an upregulation of RGS4 in heart failure.
Cardiovasc Res. 55:778–786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Owen VJ, Burton PB, Mullen AJ, Birks EJ,
Barton P and Yacoub MH: Expression of RGS3, RGS4 and Gi alpha 2 in
acutely failing donor hearts and end-stage heart failure. Eur Heart
J. 22:1015–1020. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie Y, Wolff DW, Wei T, Wang B, Deng C,
Kirui JK, Jiang H, Qin J, Abel PW and Tu Y: Breast cancer migration
and invasion depend on proteasome degradation of regulator of
G-protein signaling 4. Cancer Res. 69:5743–5751. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee PC, Sowa ME, Gygi SP and Harper JW:
Alternative ubiquitin activation/conjugation cascades interact with
N-end rule ubiquitin ligases to control degradation of RGS
proteins. Mol Cell. 43:392–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davydov IV and Varshavsky A: RGS4 is
arginylated and degraded by the N-end rule pathway in vitro. J Biol
Chem. 275:22931–22941. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Popov S, Yu K, Kozasa T and Wilkie TM: The
regulators of G protein signaling (RGS) domains of RGS4, RGS10, and
GAIP retain GTPase activating protein activity in vitro. Proc Natl
Acad Sci USA. 94:7216–7220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hubbard KB and Hepler JR: Cell signalling
diversity of the Gqalpha family of heterotrimeric G proteins. Cell
Signal. 18:135–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tirziu D and Simons M: Endothelium-driven
myocardial growth or nitric oxide at the crossroads. Trends
Cardiovasc Med. 18:299–305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Van Berlo JH, Maillet M and Molkentin JD:
Signaling effectors underlying pathologic growth and remodeling of
the heart. J Clin Invest. 123:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dupré DJ, Robitaille M, Rebois RV and
Hébert TE: The role of Gbetagamma subunits in the organization,
assembly, and function of GPCR signaling complexes. Annu Rev
Pharmacol Toxicol. 49:31–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Levitt P, Ebert P, Mirnics K, Nimgaonkar
VL and Lewis DA: Making the case for a candidate vulnerability gene
in schizophrenia: Convergent evidence for regulator of G-protein
signaling 4 (RGS4). Biol Psychiatry. 60:534–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tekumalla PK, Calon F, Rahman Z, Birdi S,
Rajput AH, Hornykiewicz O, Di Paolo T, Bédard PJ and Nestler EJ:
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's
disease. Biol Psychiatry. 50:813–816. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kelly P, Moeller BJ, Juneja J, Booden MA,
Der CJ, Daaka Y, Dewhirst MW, Fields TA and Casey PJ: The G12
family of heterotrimeric G proteins promotes breast cancer invasion
and metastasis. Proc Natl Acad Sci USA. 103:8173–8178. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riccardi C and Nicoletti I: Analysis of
apoptosis by propidium iodide staining and flow cytometry. Nat
Protoc. 1:1458–1461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang TH, Wang HS and Soong YK:
Paclitaxel-induced cell death: Where the cell cycle and apoptosis
come together. Cancer. 88:2619–2628. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O'Reilly KE, Rojo F, She QB, Solit D,
Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, et al:
mTOR inhibition induces upstream receptor tyrosine kinase signaling
and activates Akt. Cancer Res. 66:1500–1508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bodenstein J, Sunahara RK and Neubig RR:
N-terminal residues control proteasomal degradation of RGS2, RGS4
and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol.
71:1040–1050. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krumins AM, Barker SA, Huang C, Sunahara
RK, Yu K, Wilkie TM, Gold SJ and Mumby SM: Differentially regulated
expression of endogenous RGS4 and RGS7. J Biol Chem. 279:2593–2599.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanchez Y, Wong C, Thoma RS, Richman R, Wu
Z, Piwnica-Worms H and Elledge SJ: Conservation of the Chk1
checkpoint pathway in mammals: Linkage of DNA damage to Cdk
regulation through Cdc25. Science. 277:1497–1501. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw
AS and Piwnica-Worms H: Mitotic and G2 checkpoint control:
Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C
on serine-216. Science. 277:1501–1505. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumagai A and Dunphy WG: Binding of 14-3-3
proteins and nuclear export control the intracellular localization
of the mitotic inducer Cdc25. Genes Dev. 13:1067–1072. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dumesic PA, Scholl FA, Barragan DI and
Khavari PA: Erk1/2 MAP kinases are required for epidermal G2/M
progression. J Cell Biol. 185:409–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Palmer A, Gavin AC and Nebreda AR: A link
between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation:
p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory
kinase Myt1. EMBO J. 17:5037–5047. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chambard JC, Lefloch R, Pouysségur J and
Lenormand P: ERK implication in cell cycle regulation. Biochim
Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L and Madura K: Increased proteasome
activity, ubiquitin-conjugating enzymes, and eEF1A translation
factor detected in breast cancer tissue. Cancer Res. 65:5599–5606.
2005. View Article : Google Scholar : PubMed/NCBI
|
